Smartstop Self Storage REIT (NYSE:SMA) Raised to “Strong-Buy” at Raymond James Financial

Smartstop Self Storage REIT (NYSE:SMA) was upgraded by investment analysts at Raymond James Financial to a “strong-buy” rating in a research note issued on Wednesday,Zacks.com reports.

Several other brokerages also recently issued reports on SMA. JPMorgan Chase & Co. cut their target price on shares of Smartstop Self Storage REIT from $35.00 to $32.00 and set an “underweight” rating on the stock in a research note on Monday, March 23rd. Wells Fargo & Company raised their target price on Smartstop Self Storage REIT from $30.00 to $32.00 and gave the stock an “equal weight” rating in a research report on Monday, June 1st. Weiss Ratings upgraded Smartstop Self Storage REIT from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Zacks Research raised Smartstop Self Storage REIT from a “strong sell” rating to a “hold” rating in a research report on Friday, May 8th. Finally, Scotiabank raised Smartstop Self Storage REIT to a “strong-buy” rating in a research note on Thursday, March 19th. Two analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Smartstop Self Storage REIT has an average rating of “Moderate Buy” and an average price target of $36.31.

Smartstop Self Storage REIT Stock Performance

Smartstop Self Storage REIT stock opened at $35.02 on Wednesday. Smartstop Self Storage REIT has a fifty-two week low of $29.41 and a fifty-two week high of $39.77. The firm’s 50 day simple moving average is $32.03 and its 200-day simple moving average is $32.03. The company has a debt-to-equity ratio of 0.86, a current ratio of 5.33 and a quick ratio of 5.33. The company has a market cap of $1.94 billion, a P/E ratio of 233.43 and a beta of 0.56.

Smartstop Self Storage REIT (NYSE:SMA) last issued its quarterly earnings results on Wednesday, May 6th. The healthcare company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.48 by $0.01. Smartstop Self Storage REIT had a net margin of 4.38% and a return on equity of 1.00%. The business had revenue of $78.31 million during the quarter, compared to the consensus estimate of $72.56 million. The business’s revenue for the quarter was up 19.7% on a year-over-year basis. Smartstop Self Storage REIT has set its FY 2026 guidance at 1.940-2.040 EPS. As a group, equities research analysts predict that Smartstop Self Storage REIT will post 2.01 EPS for the current year.

Hedge Funds Weigh In On Smartstop Self Storage REIT

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Principal Financial Group Inc. lifted its stake in Smartstop Self Storage REIT by 10,361.9% in the fourth quarter. Principal Financial Group Inc. now owns 2,067,159 shares of the healthcare company’s stock valued at $63,958,000 after acquiring an additional 2,047,400 shares during the last quarter. Vanguard Group Inc. increased its stake in shares of Smartstop Self Storage REIT by 122.2% during the 4th quarter. Vanguard Group Inc. now owns 3,576,922 shares of the healthcare company’s stock worth $110,670,000 after purchasing an additional 1,967,321 shares during the last quarter. Conversant Capital LLC acquired a new position in shares of Smartstop Self Storage REIT during the 2nd quarter worth $36,098,000. Price T Rowe Associates Inc. MD raised its holdings in shares of Smartstop Self Storage REIT by 13.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 5,913,679 shares of the healthcare company’s stock valued at $182,972,000 after purchasing an additional 710,871 shares in the last quarter. Finally, Rush Island Management LP bought a new position in shares of Smartstop Self Storage REIT during the 4th quarter valued at $15,644,000.

Smartstop Self Storage REIT Company Profile

Symmetry Medical Inc (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry.